-
1
-
-
0035968189
-
Updated U.S Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis
-
CDC. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2001;50(No. RR-11):1-52
-
(2001)
MMWR Recomm Rep
, vol.50
, Issue.RR-11
, pp. 1-52
-
-
-
2
-
-
0035893422
-
PHS guidelines for management of occupational exposure to HBV, HCV and HIV: management of occupational blood exposures
-
Preboth M. PHS guidelines for management of occupational exposure to HBV, HCV and HIV: management of occupational blood exposures. Am Fam Physician 2001;64:2012-4
-
(2001)
Am Fam Physician
, vol.64
, pp. 2012-2014
-
-
Preboth, M.1
-
3
-
-
0019874508
-
Survival of hepatitis B virus after drying and storage for one week
-
Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet 1981;317:550-1. https://doi.org/10.1016/S0140-6736(81)92877-4
-
(1981)
Lancet
, vol.317
, pp. 550-551
-
-
Bond, W.W.1
Favero, M.S.2
Petersen, N.J.3
Gravelle, C.R.4
Ebert, J.W.5
Maynard, J.E.6
-
4
-
-
84857504712
-
-
Atlanta, GA: US Department of Health and Human Services, CDC
-
CDC. Viral hepatitis-statistics and surveillance. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. https://www. cdc.gov/hepatitis/statistics/
-
(2017)
Viral hepatitis-statistics and surveillance
-
-
-
5
-
-
84951825509
-
AASLD guidelines for treatment of chronic hepatitis B
-
Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH; American Association for the Study of Liver Diseases. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016;63:261-83. https://doi.org/10.1002/hep.28156
-
(2016)
Hepatology
, vol.63
, pp. 261-283
-
-
Terrault, N.A.1
Bzowej, N.H.2
Chang, K.M.3
Hwang, J.P.4
Jonas, M.M.5
Murad, M.H.6
-
6
-
-
84892707488
-
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host
-
Rubin LG, Levin MJ, Ljungman P, et al.; Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014;58:e44-100. https:// doi.org/10.1093/cid/cit684
-
(2014)
Clin Infect Dis
, vol.58
, pp. e44-e100
-
-
Rubin, L.G.1
Levin, M.J.2
Ljungman, P.3
-
7
-
-
33644698390
-
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP Part 1: immunization of infants, children, and adolescents
-
Mast EE, Margolis HS, Fiore AE, et al.; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005;54(No. RR-16):1-31
-
(2005)
MMWR Recomm Rep
, vol.54
, Issue.RR-16
, pp. 1-31
-
-
Mast, E.E.1
Margolis, H.S.2
Fiore, A.E.3
-
8
-
-
39049191182
-
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults
-
Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults. MMWR Recomm Rep 2006;55(No. RR-16):1-33
-
(2006)
MMWR Recomm Rep
, vol.55
, Issue.RR-16
, pp. 1-33
-
-
Mast, E.E.1
Weinbaum, C.M.2
Fiore, A.E.3
-
9
-
-
84255162321
-
Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
CDC. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011;60:1709-11
-
(2011)
MMWR Morb Mortal Wkly Rep
, vol.60
, pp. 1709-1711
-
-
-
10
-
-
84900555870
-
CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management
-
Schillie S, Murphy TV, Sawyer M, et al.; CDC. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 2013;62(No. RR-10):1-19
-
(2013)
MMWR Recomm Rep
, vol.62
, Issue.RR-10
, pp. 1-19
-
-
Schillie, S.1
Murphy, T.V.2
Sawyer, M.3
-
11
-
-
84944461092
-
Update: shortened interval for postvaccination serologic testing of infants born to hepatitis b-infected mothers
-
Schillie S, Murphy TV, Fenlon N, Ko S, Ward JW. Update: shortened interval for postvaccination serologic testing of infants born to hepatitis b-infected mothers. MMWR Morb Mortal Wkly Rep 2015;64:1118-20
-
(2015)
MMWR Morb Mortal Wkly Rep
, vol.64
, pp. 1118-1120
-
-
Schillie, S.1
Murphy, T.V.2
Fenlon, N.3
Ko, S.4
Ward, J.W.5
-
12
-
-
84939569983
-
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
-
Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2015;33:4398-405. https://doi.org/10.1016/j.vaccine.2015.07.035
-
(2015)
Vaccine
, vol.33
, pp. 4398-4405
-
-
Shimabukuro, T.T.1
Nguyen, M.2
Martin, D.3
DeStefano, F.4
-
13
-
-
0038341614
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001
-
Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ 2003;52(No. SS-1):1-24
-
(2003)
MMWR Surveill Summ
, vol.52
, pp. 1-24
-
-
Zhou, W.1
Pool, V.2
Iskander, J.K.3
-
14
-
-
84922289175
-
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
-
McNeil MM, Gee J, Weintraub ES, et al. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine 2014;32:5390-8. https://doi.org/10.1016/j.vaccine.2014.07.073
-
(2014)
Vaccine
, vol.32
, pp. 5390-5398
-
-
McNeil, M.M.1
Gee, J.2
Weintraub, E.S.3
-
15
-
-
60849083013
-
-
Atlanta, GA: US Department of Health and Human Services, CDC; 2010
-
CDC. Surveillance data for acute viral hepatitis-United States, 2008. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. https://www.cdc.gov/hepatitis/statistics/2008surveillance/index.htm
-
(2008)
Surveillance data for acute viral hepatitis-United States
-
-
-
16
-
-
84959259569
-
Increases in acute hepatitis B virus infections-Kentucky, Tennessee, and West Virginia, 2006-2013
-
Harris AM, Iqbal K, Schillie S, et al. Increases in acute hepatitis B virus infections-Kentucky, Tennessee, and West Virginia, 2006-2013. MMWR Morb Mortal Wkly Rep 2016;65:47-50
-
(2016)
MMWR Morb Mortal Wkly Rep
, vol.65
, pp. 47-50
-
-
Harris, A.M.1
Iqbal, K.2
Schillie, S.3
-
17
-
-
84956795310
-
Prevalence of chronic hepatitis B virus (HBV) infection in U. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012
-
Roberts H, Kruszon-Moran D, Ly KN, et al. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012. Hepatology 2016;63:388-97. https://doi.org/10.1002/hep.28109
-
(2016)
Hepatology
, vol.63
, pp. 388-397
-
-
Roberts, H.1
Kruszon-Moran, D.2
Ly, K.N.3
-
18
-
-
77954589063
-
The prevalence of hepatitis B virus infection in the United States in the era of vaccination
-
Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010;202:192-201. https://doi.org/10.1086/653622
-
(2010)
J Infect Dis
, vol.202
, pp. 192-201
-
-
Wasley, A.1
Kruszon-Moran, D.2
Kuhnert, W.3
-
19
-
-
84864336274
-
Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin
-
Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 2012;56:422-33. https://doi. org/10.1002/hep.24804
-
(2012)
Hepatology
, vol.56
, pp. 422-433
-
-
Kowdley, K.V.1
Wang, C.C.2
Welch, S.3
Roberts, H.4
Brosgart, C.L.5
-
20
-
-
82855177828
-
The increasing burden of imported chronic hepatitis B-United States, 1974-2008
-
Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA. The increasing burden of imported chronic hepatitis B-United States, 1974-2008. PLoS One 2011;6:e27717. https://doi.org/10.1371/ journal.pone.0027717
-
(2011)
PLoS One
, vol.6
-
-
Mitchell, T.1
Armstrong, G.L.2
Hu, D.J.3
Wasley, A.4
Painter, J.A.5
-
21
-
-
0026430024
-
Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination Recommendations of the Immunization Practices Advisory Committee (ACIP)
-
CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991;40(No. RR-13):1-25
-
(1991)
MMWR Recomm Rep
, vol.40
, Issue.RR-13
, pp. 1-25
-
-
-
22
-
-
0020490799
-
Recommendation of the Immunization Practices Advisory Committee (ACIP) Inactivated hepatitis B virus vaccine
-
CDC. Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep 1982;31:317-22, 327-8
-
(1982)
MMWR Morb Mortal Wkly Rep
, vol.31
-
-
-
23
-
-
0024294522
-
Changing patterns of groups at high risk for hepatitis B in the United States
-
CDC. Changing patterns of groups at high risk for hepatitis B in the United States. MMWR Morb Mortal Wkly Rep 1988;37:429-32, 437
-
(1988)
MMWR Morb Mortal Wkly Rep
, vol.37
-
-
-
24
-
-
0024295819
-
Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings
-
CDC. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 1988;37:377-82, 387-8
-
(1988)
MMWR Morb Mortal Wkly Rep
, vol.37
-
-
-
25
-
-
0024283314
-
Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen
-
CDC. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR Morb Mortal Wkly Rep 1988;37:341-6, 351
-
(1988)
MMWR Morb Mortal Wkly Rep
, vol.37
-
-
-
26
-
-
0033593156
-
Update: recommendations to prevent hepatitis B virus transmission-United States
-
CDC. Update: recommendations to prevent hepatitis B virus transmission-United States. MMWR Morb Mortal Wkly Rep 1999;48:33-4
-
(1999)
MMWR Morb Mortal Wkly Rep
, vol.48
, pp. 33-34
-
-
-
27
-
-
85007443321
-
Hepatitis B surface antigen testing among pregnant women, United States 2014
-
Kolasa MS, Tsai Y, Xu J, Fenlon N, Schillie S. Hepatitis B surface antigen testing among pregnant women, United States 2014. Pediatr Infect Dis J 2017;36:e175-80. https://doi.org/10.1097/INF.0000000000001516
-
(2017)
Pediatr Infect Dis J
, vol.36
, pp. e175-e180
-
-
Kolasa, M.S.1
Tsai, Y.2
Xu, J.3
Fenlon, N.4
Schillie, S.5
-
28
-
-
84902651610
-
Prevention of vertical transmission of hepatitis B: an observational study
-
Kubo A, Shlager L, Marks AR, et al. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med 2014;160:828-35. https://doi.org/10.7326/M13-2529
-
(2014)
Ann Intern Med
, vol.160
, pp. 828-835
-
-
Kubo, A.1
Shlager, L.2
Marks, A.R.3
-
29
-
-
84929492457
-
Outcomes of infants born to women infected with hepatitis B
-
Schillie S, Walker T, Veselsky S, et al. Outcomes of infants born to women infected with hepatitis B. Pediatrics 2015;135:e1141-7. https:// doi.org/10.1542/peds.2014-3213
-
(2015)
Pediatrics
, vol.135
, pp. e1141-e1147
-
-
Schillie, S.1
Walker, T.2
Veselsky, S.3
-
30
-
-
85032896834
-
Vaccination coverage among children aged 19-35 months-United States, 2016
-
Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kang Y. Vaccination coverage among children aged 19-35 months-United States, 2016. MMWR Morb Mortal Wkly Rep 2017;66:1171-7. https://doi. org/10.15585/mmwr.mm6643a3
-
(2017)
MMWR Morb Mortal Wkly Rep
, vol.66
, pp. 1171-1177
-
-
Hill, H.A.1
Elam-Evans, L.D.2
Yankey, D.3
Singleton, J.A.4
Kang, Y.5
-
31
-
-
48449107020
-
Newborn hepatitis B vaccination coverage among children born January 2003-June 2005-United States
-
CDC. Newborn hepatitis B vaccination coverage among children born January 2003-June 2005-United States. MMWR Morb Mortal Wkly Rep 2008;57:825-8
-
(2008)
MMWR Morb Mortal Wkly Rep
, vol.57
, pp. 825-828
-
-
-
32
-
-
73649114662
-
-
Washington, DC: US Department of Health and Human Services
-
US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2014. https:// www.healthypeople.gov/
-
(2014)
Healthy people 2020
-
-
-
33
-
-
85029006744
-
National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2016
-
Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2016. MMWR Morb Mortal Wkly Rep 2017;66:874-82
-
(2017)
MMWR Morb Mortal Wkly Rep
, vol.66
, pp. 874-882
-
-
Walker, T.Y.1
Elam-Evans, L.D.2
Singleton, J.A.3
-
34
-
-
85019171511
-
Surveillance of vaccination coverage among adult populations-United States, 2015
-
Williams WW, Lu PJ, O'Halloran A, et al.; CDC. Surveillance of vaccination coverage among adult populations-United States, 2015. MMWR Surveill Summ 2017;66(No. SS-11):1-28
-
(2017)
MMWR Surveill Summ
, vol.66
, pp. 1-28
-
-
Williams, W.W.1
Lu, P.J.2
O'Halloran, A.3
-
35
-
-
0029298360
-
Impact of the bloodborne pathogens standard on vaccination of healthcare workers with hepatitis B vaccine
-
Agerton TB, Mahoney FJ, Polish LB, Shapiro CN. Impact of the bloodborne pathogens standard on vaccination of healthcare workers with hepatitis B vaccine. Infect Control Hosp Epidemiol 1995;16:287-91. https://doi.org/10.2307/30143095
-
(1995)
Infect Control Hosp Epidemiol
, vol.16
, pp. 287-291
-
-
Agerton, T.B.1
Mahoney, F.J.2
Polish, L.B.3
Shapiro, C.N.4
-
36
-
-
84900397445
-
Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load
-
Fan L, Owusu-Edusei K Jr, Schillie SF, Murphy TV. Cost-effectiveness of testing hepatitis B-positive pregnant women for hepatitis B e antigen or viral load. Obstet Gynecol 2014;123:929-37. https://doi.org/10.1097/ AOG.0000000000000124
-
(2014)
Obstet Gynecol
, vol.123
, pp. 929-937
-
-
Fan, L.1
Owusu-Edusei, K.2
Schillie, S.F.3
Murphy, T.V.4
-
37
-
-
84970026275
-
-
Screening pregnant women for hepatitis B virus (HBV) infection. Atlanta, GA: US Department of Health and Human Services, CDC
-
CDC; The American College of Obstetricians and Gynecologists. Screening pregnant women for hepatitis B virus (HBV) infection. Atlanta, GA: US Department of Health and Human Services, CDC; 2015 https://www.cdc.gov/hepatitis/hbv/pdfs/prenatalhbsagtesting.pdf
-
(2015)
The American College of Obstetricians and Gynecologists
-
-
-
38
-
-
84862777352
-
An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus
-
Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol 2012;10:452-9. https:// doi.org/10.1016/j.cgh.2011.10.041
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 452-459
-
-
Pan, C.Q.1
Duan, Z.P.2
Bhamidimarri, K.R.3
-
39
-
-
84862776962
-
Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B
-
Pan CQ, Han GR, Jiang HX, et al. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol 2012;10:520-6. https://doi.org/10.1016/j. cgh.2012.01.019
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 520-526
-
-
Pan, C.Q.1
Han, G.R.2
Jiang, H.X.3
-
40
-
-
33846085749
-
Immunopathogenesis of hepatitis B virus infection
-
Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007;85:16-23. https://doi.org/10.1038/ sj.icb.7100009
-
(2007)
Immunol Cell Biol
, vol.85
, pp. 16-23
-
-
Chang, J.J.1
Lewin, S.R.2
-
41
-
-
84940195264
-
Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities
-
Gish RG, Given BD, Lai CL, et al. Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities. Antiviral Res 2015;121:47-58. https://doi.org/10.1016/j. antiviral.2015.06.008
-
(2015)
Antiviral Res
, vol.121
, pp. 47-58
-
-
Gish, R.G.1
Given, B.D.2
Lai, C.L.3
-
42
-
-
0025765813
-
Serologic diagnosis of acute and chronic viral hepatitis
-
Hoofnagle JH, Di Bisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 1991;11:73-83. https://doi. org/10.1055/s-2008-1040426
-
(1991)
Semin Liver Dis
, vol.11
, pp. 73-83
-
-
Hoofnagle, J.H.1
Di Bisceglie, A.M.2
-
43
-
-
0018394957
-
Viral hepatitis, type B Studies on natural history and prevention re-examined
-
Krugman S, Overby LR, Mushahwar IK, Ling CM, Frösner GG, Deinhardt F. Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med 1979;300:101-6. https://doi. org/10.1056/NEJM197901183000301
-
(1979)
N Engl J Med
, vol.300
, pp. 101-106
-
-
Krugman, S.1
Overby, L.R.2
Mushahwar, I.K.3
Ling, C.M.4
Frösner, G.G.5
Deinhardt, F.6
-
45
-
-
0028877043
-
Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene
-
Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 1995;38:24-34. https://doi.org/10.1159/000150411
-
(1995)
Intervirology
, vol.38
, pp. 24-34
-
-
Magnius, L.O.1
Norder, H.2
-
46
-
-
84904648921
-
Genotypes and genetic variability of hepatitis B virus
-
Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology 2014;57:141-50. https://doi.org/10.1159/000360947
-
(2014)
Intervirology
, vol.57
, pp. 141-150
-
-
Kramvis, A.1
-
47
-
-
84978865139
-
The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics
-
Kramvis A. The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. Rev Med Virol 2016;26:285-303. https://doi. org/10.1002/rmv.1885
-
(2016)
Rev Med Virol
, vol.26
, pp. 285-303
-
-
Kramvis, A.1
-
48
-
-
1242293621
-
Occult hepatitis B virus infection
-
Allain JP. Occult hepatitis B virus infection. Transfus Clin Biol 2004;11:18-25. https://doi.org/10.1016/j.tracli.2003.11.007
-
(2004)
Transfus Clin Biol
, vol.11
, pp. 18-25
-
-
Allain, J.P.1
-
49
-
-
84919848147
-
Hepatitis B virus infection
-
Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet 2014;384:2053-63. https://doi.org/10.1016/S0140-6736(14)60220-8
-
(2014)
Lancet
, vol.384
, pp. 2053-2063
-
-
Trépo, C.1
Chan, H.L.2
Lok, A.3
-
50
-
-
0022000510
-
Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state
-
McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599-603. https://doi.org/10.1093/infdis/151.4.599
-
(1985)
J Infect Dis
, vol.151
, pp. 599-603
-
-
McMahon, B.J.1
Alward, W.L.2
Hall, D.B.3
-
51
-
-
0019831247
-
Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection
-
Dienstag JL. Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection. Springer Semin Immunopathol 1981;3:461-72. https://doi.org/10.1007/BF01951493
-
(1981)
Springer Semin Immunopathol
, vol.3
, pp. 461-472
-
-
Dienstag, J.L.1
-
52
-
-
0021086531
-
Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine
-
Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;322:1099-102. https:// doi.org/10.1016/S0140-6736(83)90624-4
-
(1983)
Lancet
, vol.322
, pp. 1099-1102
-
-
Beasley, R.P.1
Hwang, L.Y.2
Lee, G.C.3
-
53
-
-
0027297322
-
The influence of age on the development of the hepatitis B carrier state
-
Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 1993;253:197-201. https://doi.org/10.1098/rspb.1993.0102
-
(1993)
Proc Biol Sci
, vol.253
, pp. 197-201
-
-
Edmunds, W.J.1
Medley, G.F.2
Nokes, D.J.3
Hall, A.J.4
Whittle, H.C.5
-
54
-
-
0028945294
-
Risks of chronicity following acute hepatitis B virus infection: a review
-
Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995;20:992-1000. https://doi. org/10.1093/clinids/20.4.992
-
(1995)
Clin Infect Dis
, vol.20
, pp. 992-1000
-
-
Hyams, K.C.1
-
55
-
-
0026028252
-
Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection
-
Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991;163:454-7. https:// doi.org/10.1093/infdis/163.3.454
-
(1991)
J Infect Dis
, vol.163
, pp. 454-457
-
-
Hadler, S.C.1
Judson, F.N.2
O'Malley, P.M.3
-
56
-
-
84919580033
-
Hepatocellular carcinoma and hepatitis B virus A prospective study of 22 707 men in Taiwan
-
Beasley RP, Lin CC, Hwang LY, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981;318:1129-33. https://doi.org/10.1016/S0140-6736(81)90585-7
-
(1981)
Lancet
, vol.318
, pp. 1129-1133
-
-
Beasley, R.P.1
Lin, C.C.2
Hwang, L.Y.3
Chien, C.S.4
-
57
-
-
29244437488
-
A mathematical model to estimate global hepatitis B disease burden and vaccination impact
-
Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005;34:1329-39. https://doi. org/10.1093/ije/dyi206
-
(2005)
Int J Epidemiol
, vol.34
, pp. 1329-1339
-
-
Goldstein, S.T.1
Zhou, F.2
Hadler, S.C.3
Bell, B.P.4
Mast, E.E.5
Margolis, H.S.6
-
58
-
-
0025246255
-
Hepatitis B-related sequelae Prospective study in 1400 hepatitis B surface antigenpositive Alaska native carriers
-
McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigenpositive Alaska native carriers. Arch Intern Med 1990;150:1051-4. https://doi.org/10.1001/archinte.1990.00390170087019
-
(1990)
Arch Intern Med
, vol.150
, pp. 1051-1054
-
-
McMahon, B.J.1
Alberts, S.R.2
Wainwright, R.B.3
Bulkow, L.4
Lanier, A.P.5
-
59
-
-
84951795052
-
Antiviral therapy in management of chronic hepatitis B viral infection in children: a systematic review and meta-analysis
-
Jonas MM, Lok AS, McMahon BJ, et al. Antiviral therapy in management of chronic hepatitis B viral infection in children: a systematic review and meta-analysis. Hepatology 2016;63:307-18. https://doi.org/10.1002/ hep.28278
-
(2016)
Hepatology
, vol.63
, pp. 307-318
-
-
Jonas, M.M.1
Lok, A.S.2
McMahon, B.J.3
-
60
-
-
84951792292
-
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
-
Lok AS, McMahon BJ, Brown RS Jr, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis. Hepatology 2016;63:284-306. https://doi.org/10.1002/ hep.28280
-
(2016)
Hepatology
, vol.63
, pp. 284-306
-
-
Lok, A.S.1
McMahon, B.J.2
Brown, R.S.3
-
61
-
-
84888028453
-
Chronic hepatitis B virus infection
-
McMahon BJ. Chronic hepatitis B virus infection. Med Clin North Am 2014;98:39-54. https://doi.org/10.1016/j.mcna.2013.08.004
-
(2014)
Med Clin North Am
, vol.98
, pp. 39-54
-
-
McMahon, B.J.1
-
62
-
-
85002245074
-
Hepatitis due to reactivation of hepatitis B virus in endemic areas among patients with hepatitis C treated with direct-acting antiviral agents
-
Wang C, Ji D, Chen J, et al. Hepatitis due to reactivation of hepatitis B virus in endemic areas among patients with hepatitis C treated with direct-acting antiviral agents. Clin Gastroenterol Hepatol 2017;15:132-6. https://doi.org/10.1016/j.cgh.2016.06.023
-
(2017)
Clin Gastroenterol Hepatol
, vol.15
, pp. 132-136
-
-
Wang, C.1
Ji, D.2
Chen, J.3
-
63
-
-
84929078367
-
Prevention of perinatal hepatitis B virus transmission
-
Nelson NP, Jamieson DJ, Murphy TV. Prevention of perinatal hepatitis B virus transmission. J Pediatric Infect Dis Soc 2014;3(Suppl 1):S7-12. https://doi.org/10.1093/jpids/piu064
-
(2014)
J Pediatric Infect Dis Soc
, vol.3
, pp. S7-S12
-
-
Nelson, N.P.1
Jamieson, D.J.2
Murphy, T.V.3
-
64
-
-
84877832031
-
Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review
-
Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. Vaccine 2013;31:2506-16. https://doi.org/10.1016/j.vaccine.2012.12.012
-
(2013)
Vaccine
, vol.31
, pp. 2506-2516
-
-
Schillie, S.F.1
Murphy, T.V.2
-
65
-
-
84879459757
-
Atypical serological profiles in hepatitis B virus infection
-
Pondé RA. Atypical serological profiles in hepatitis B virus infection. Eur J Clin Microbiol Infect Dis 2013;32:461-76. https://doi.org/10.1007/ s10096-012-1781-9
-
(2013)
Eur J Clin Microbiol Infect Dis
, vol.32
, pp. 461-476
-
-
Pondé, R.A.1
-
66
-
-
76349092060
-
The underlying mechanisms for the 'anti-HBc alone' serological profile
-
Pondé RA, Cardoso DD, Ferro MO. The underlying mechanisms for the 'anti-HBc alone' serological profile. Arch Virol 2010;155:149-58. https://doi.org/10.1007/s00705-009-0559-6
-
(2010)
Arch Virol
, vol.155
, pp. 149-158
-
-
Pondé, R.A.1
Cardoso, D.D.2
Ferro, M.O.3
-
67
-
-
0024449983
-
Hepatitis B virus infection among children born in the United States to Southeast Asian refugees
-
Franks AL, Berg CJ, Kane MA, et al. Hepatitis B virus infection among children born in the United States to Southeast Asian refugees. N Engl J Med 1989;321:1301-5. https://doi.org/10.1056/ NEJM198911093211905
-
(1989)
N Engl J Med
, vol.321
, pp. 1301-1305
-
-
Franks, A.L.1
Berg, C.J.2
Kane, M.A.3
-
68
-
-
84961275659
-
Are current screening protocols for chronic hepatitis B virus infection adequate?
-
Mortensen E, Kamali A, Schirmer PL, et al. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis 2016;85:159-67. https://doi.org/10.1016/j. diagmicrobio.2015.12.005
-
(2016)
Diagn Microbiol Infect Dis
, vol.85
, pp. 159-167
-
-
Mortensen, E.1
Kamali, A.2
Schirmer, P.L.3
-
69
-
-
84902579108
-
Persistence of hepatitis B surface antigen in blood in a chronic haemodialysis patient following vaccination booster
-
jun10 1
-
Calisti G, Herman O, Powley M, Haque T. Persistence of hepatitis B surface antigen in blood in a chronic haemodialysis patient following vaccination booster. BMJ Case Rep 2014;2014(jun10 1):bcr2013202191. https:// doi.org/10.1136/bcr-2013-202191
-
(2014)
BMJ Case Rep
, vol.2014
-
-
Calisti, G.1
Herman, O.2
Powley, M.3
Haque, T.4
-
70
-
-
0033752014
-
Serological pattern 'anti-HBc alone': report on a workshop
-
Grob P, Jilg W, Bornhak H, et al. Serological pattern 'anti-HBc alone': report on a workshop. J Med Virol 2000;62:450-5. https://doi. org/10.1002/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y
-
(2000)
J Med Virol
, vol.62
, pp. 450-455
-
-
Grob, P.1
Jilg, W.2
Bornhak, H.3
-
71
-
-
17344367723
-
Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine
-
Silva AE, McMahon BJ, Parkinson AJ, Sjogren MH, Hoofnagle JH, Di Bisceglie AM. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis 1998;26:895-7. https://doi.org/10.1086/513918
-
(1998)
Clin Infect Dis
, vol.26
, pp. 895-897
-
-
Silva, A.E.1
McMahon, B.J.2
Parkinson, A.J.3
Sjogren, M.H.4
Hoofnagle, J.H.5
Di Bisceglie, A.M.6
-
72
-
-
84868676890
-
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence
-
Candotti D, Lin CK, Belkhiri D, et al. Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut 2012;61:1744-53. https:// doi.org/10.1136/gutjnl-2011-301281
-
(2012)
Gut
, vol.61
, pp. 1744-1753
-
-
Candotti, D.1
Lin, C.K.2
Belkhiri, D.3
-
73
-
-
17844400580
-
Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study
-
De Feo TM, Poli F, Mozzi F, Moretti MP, Scalamogna M; Collaborative Kidney, Liver and Heart North Italy Transplant Program Study Groups. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study. Transplant Proc 2005;37:1238-9. https://doi.org/10.1016/j.transproceed.2004.12.041
-
(2005)
Transplant Proc
, vol.37
, pp. 1238-1239
-
-
De Feo, T.M.1
Poli, F.2
Mozzi, F.3
Moretti, M.P.4
Scalamogna, M.5
-
74
-
-
85041902296
-
-
Atlanta, GA: Council of State and Territorial Epidemiologists
-
Council of State and Territorial Epidemiologists. Hepatitis B, perinatal virus infection 2017 case definition. Atlanta, GA: Council of State and Territorial Epidemiologists; 2017. https://wwwn.cdc.gov/nndss/ conditions/hepatitis-b-perinatal-virus-infection/case-definition/2017/
-
(2017)
Hepatitis B, perinatal virus infection 2017 case definition
-
-
-
75
-
-
80051676859
-
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
-
Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011;378:571-83. https://doi.org/10.1016/ S0140-6736(11)61097-0
-
(2011)
Lancet
, vol.378
, pp. 571-583
-
-
Nelson, P.K.1
Mathers, B.M.2
Cowie, B.3
-
77
-
-
0026585643
-
Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees
-
Hurie MB, Mast EE, Davis JP. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. Pediatrics 1992;89:269-73
-
(1992)
Pediatrics
, vol.89
, pp. 269-273
-
-
Hurie, M.B.1
Mast, E.E.2
Davis, J.P.3
-
78
-
-
0017613292
-
Prevalence of hepatitis B infection among residents of an institution for the mentally retarded
-
Chaudhary RK, Perry E, Cleary TE. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded. Am J Epidemiol 1977;105:123-6. https://doi.org/10.1093/oxfordjournals.aje.a112363
-
(1977)
Am J Epidemiol
, vol.105
, pp. 123-126
-
-
Chaudhary, R.K.1
Perry, E.2
Cleary, T.E.3
-
79
-
-
58149384017
-
Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008
-
Thompson ND, Perz JF, Moorman AC, Holmberg SD. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 2009;150:33-9. https://doi. org/10.7326/0003-4819-150-1-200901060-00007
-
(2009)
Ann Intern Med
, vol.150
, pp. 33-39
-
-
Thompson, N.D.1
Perz, J.F.2
Moorman, A.C.3
Holmberg, S.D.4
-
80
-
-
84862791083
-
Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak
-
Williams RE, Sena AC, Moorman AC, et al. Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak. Vaccine 2012;30:3147-50. https://doi. org/10.1016/j.vaccine.2012.02.078
-
(2012)
Vaccine
, vol.30
, pp. 3147-3150
-
-
Williams, R.E.1
Sena, A.C.2
Moorman, A.C.3
-
81
-
-
0036314701
-
Prevalence of hepatitis virus infections in an institution for persons with developmental disabilities
-
Woodruff BA, Vazquez E. Prevalence of hepatitis virus infections in an institution for persons with developmental disabilities. Am J Ment Retard 2002;107:278-92. https://doi. org/10.1352/0895-8017(2002)107<0278:POHVII>2.0.CO;2
-
(2002)
Am J Ment Retard
, vol.107
, pp. 278-292
-
-
Woodruff, B.A.1
Vazquez, E.2
-
82
-
-
0035163889
-
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness
-
Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001;91:31-7
-
(2001)
Am J Public Health
, vol.91
, pp. 31-37
-
-
Rosenberg, S.D.1
Goodman, L.A.2
Osher, F.C.3
-
83
-
-
52649120886
-
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection
-
Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008;57(No. RR-8):1-20
-
(2008)
MMWR Recomm Rep
, vol.57
, Issue.RR-8
, pp. 1-20
-
-
Weinbaum, C.M.1
Williams, I.2
Mast, E.E.3
-
84
-
-
0037462736
-
Prevention and control of infections with hepatitis viruses in correctional settings
-
Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep 2003;52(No. RR-1):1-36
-
(2003)
MMWR Recomm Rep
, vol.52
, Issue.RR-1
, pp. 1-36
-
-
Weinbaum, C.1
Lyerla, R.2
Margolis, H.S.3
-
85
-
-
0020063285
-
Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?
-
Dienstag JL, Ryan DM. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol 1982;115:26-39. https://doi.org/10.1093/oxfordjournals.aje.a113277
-
(1982)
Am J Epidemiol
, vol.115
, pp. 26-39
-
-
Dienstag, J.L.1
Ryan, D.M.2
-
86
-
-
0021966708
-
Occupational risk of hepatitis B infection in hospital workers
-
Hadler SC, Doto IL, Maynard JE, et al. Occupational risk of hepatitis B infection in hospital workers. Infect Control 1985;6:24-31. https://doi.org/10.1017/S0195941700062457
-
(1985)
Infect Control
, vol.6
, pp. 24-31
-
-
Hadler, S.C.1
Doto, I.L.2
Maynard, J.E.3
-
88
-
-
0035957964
-
Recommendations for preventing transmission of infections among chronic hemodialysis patients
-
CDC. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001;50(No. RR-5):1-43
-
(2001)
MMWR Recomm Rep
, vol.50
, Issue.RR-5
, pp. 1-43
-
-
-
89
-
-
0022456496
-
Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States
-
Alter MJ, Favero MS, Maynard JE. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis 1986;153:1149-51. https://doi.org/10.1093/ infdis/153.6.1149
-
(1986)
J Infect Dis
, vol.153
, pp. 1149-1151
-
-
Alter, M.J.1
Favero, M.S.2
Maynard, J.E.3
-
90
-
-
14844335024
-
National surveillance of dialysis-associated diseases in the United States, 2002
-
Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005;18:52-61. https://doi.org/10.1111/j.1525-139X.2005.18108.x
-
(2005)
Semin Dial
, vol.18
, pp. 52-61
-
-
Finelli, L.1
Miller, J.T.2
Tokars, J.I.3
Alter, M.J.4
Arduino, M.J.5
-
91
-
-
84931060835
-
Increases in hepatitis C virus infection related to injection drug use among persons aged =30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012
-
Zibbell JE, Iqbal K, Patel RC, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged =30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep 2015;64:453-8
-
(2015)
MMWR Morb Mortal Wkly Rep
, vol.64
, pp. 453-458
-
-
Zibbell, J.E.1
Iqbal, K.2
Patel, R.C.3
-
92
-
-
0034487235
-
Hepatitis A and hepatitis B vaccination of patients with chronic liver disease
-
Bell BP. Hepatitis A and hepatitis B vaccination of patients with chronic liver disease. Acta Gastroenterol Belg 2000;63:359-63
-
(2000)
Acta Gastroenterol Belg
, vol.63
, pp. 359-363
-
-
Bell, B.P.1
-
93
-
-
84876286108
-
Hepatitis B and C infection in international travelers
-
Johnson DF, Leder K, Torresi J. Hepatitis B and C infection in international travelers. J Travel Med 2013;20:194-202. https://doi. org/10.1111/jtm.12026
-
(2013)
J Travel Med
, vol.20
, pp. 194-202
-
-
Johnson, D.F.1
Leder, K.2
Torresi, J.3
-
94
-
-
0042442264
-
Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects
-
Kellerman SE, Hanson DL, McNaghten AD, Fleming PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 2003;188:571-7. https://doi.org/10.1086/377135
-
(2003)
J Infect Dis
, vol.188
, pp. 571-577
-
-
Kellerman, S.E.1
Hanson, D.L.2
McNaghten, A.D.3
Fleming, P.L.4
-
95
-
-
75749135627
-
Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years
-
Chun HM, Fieberg AM, Hullsiek KH, et al.; Infectious Disease Clinical Research Program HIV Working Group. Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clin Infect Dis 2010;50:426-36. https://doi. org/10.1086/649885
-
(2010)
Clin Infect Dis
, vol.50
, pp. 426-436
-
-
Chun, H.M.1
Fieberg, A.M.2
Hullsiek, K.H.3
-
96
-
-
0025972672
-
High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection
-
Homann C, Krogsgaard K, Pedersen C, Andersson P, Nielsen JO. High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection. J Acquir Immune Defic Syndr 1991;4:416-20
-
(1991)
J Acquir Immune Defic Syndr
, vol.4
, pp. 416-420
-
-
Homann, C.1
Krogsgaard, K.2
Pedersen, C.3
Andersson, P.4
Nielsen, J.O.5
-
97
-
-
0037607496
-
Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment
-
Thio CL. Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. Semin Liver Dis 2003;23:125-36. https://doi.org/10.1055/s-2003-39951
-
(2003)
Semin Liver Dis
, vol.23
, pp. 125-136
-
-
Thio, C.L.1
-
98
-
-
30144437514
-
Epidemiology of viral hepatitis and HIV co-infection
-
Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006;44(Suppl):S6-9. https://doi.org/10.1016/j. jhep.2005.11.004
-
(2006)
J Hepatol
, vol.44
, pp. S6-S9
-
-
Alter, M.J.1
-
99
-
-
0037079352
-
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
-
Thio CL, Seaberg EC, Skolasky R Jr, et al.; Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002;360:1921-6. https://doi.org/10.1016/S0140-6736(02)11913-1
-
(2002)
Lancet
, vol.360
, pp. 1921-1926
-
-
Thio, C.L.1
Seaberg, E.C.2
Skolasky, R.3
-
100
-
-
84873144487
-
Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus
-
Reilly ML, Schillie SF, Smith E, et al. Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus. J Diabetes Sci Technol 2012;6:858-66. https://doi.org/10.1177/193229681200600417
-
(2012)
J Diabetes Sci Technol
, vol.6
, pp. 858-866
-
-
Reilly, M.L.1
Schillie, S.F.2
Smith, E.3
-
101
-
-
84864716897
-
Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999-2010
-
Schillie SF, Xing J, Murphy TV, Hu DJ. Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999-2010. J Viral Hepat 2012;19:674-6. https://doi. org/10.1111/j.1365-2893.2012.01616.x
-
(2012)
J Viral Hepat
, vol.19
, pp. 674-676
-
-
Schillie, S.F.1
Xing, J.2
Murphy, T.V.3
Hu, D.J.4
-
102
-
-
0026569484
-
Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device
-
Polish LB, Shapiro CN, Bauer F, et al. Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med 1992;326:721-5. https://doi.org/10.1056/ NEJM199203123261101
-
(1992)
N Engl J Med
, vol.326
, pp. 721-725
-
-
Polish, L.B.1
Shapiro, C.N.2
Bauer, F.3
-
103
-
-
0022744580
-
Production and immunological analysis of recombinant hepatitis B vaccine
-
Emini EA, Ellis RW, Miller WJ, McAleer WJ, Scolnick EM, Gerety RJ. Production and immunological analysis of recombinant hepatitis B vaccine. J Infect 1986;13(Suppl A):3-9. https://doi. org/10.1016/S0163-4453(86)92563-6
-
(1986)
J Infect
, vol.13
, pp. 3-9
-
-
Emini, E.A.1
Ellis, R.W.2
Miller, W.J.3
McAleer, W.J.4
Scolnick, E.M.5
Gerety, R.J.6
-
104
-
-
30744471916
-
Development and production aspects of a recombinant yeast-derived hepatitis B vaccine
-
discussion S79-80
-
Stephenne J. Development and production aspects of a recombinant yeast-derived hepatitis B vaccine. Vaccine 1990;8(Suppl):S69-73, discussion S79-80
-
(1990)
Vaccine
, vol.8
, pp. S69-S73
-
-
Stephenne, J.1
-
105
-
-
0034697952
-
Update: expanded availability of thimerosal preservative-free hepatitis B vaccine
-
CDC. Update: expanded availability of thimerosal preservative-free hepatitis B vaccine. MMWR Morb Mortal Wkly Rep 2000;49:642-51
-
(2000)
MMWR Morb Mortal Wkly Rep
, vol.49
, pp. 642-651
-
-
-
106
-
-
85041920734
-
-
Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration
-
US Food and Drug Administration. Licensed biological products with supporting documents. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2017. https:// www.fda.gov/biologicsbloodvaccines/ucm133705.htm
-
(2017)
Licensed biological products with supporting documents
-
-
-
107
-
-
0033019389
-
What level of hepatitis B antibody is protective?
-
Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis 1999;179:489-92. https://doi.org/10.1086/314578
-
(1999)
J Infect Dis
, vol.179
, pp. 489-492
-
-
Jack, A.D.1
Hall, A.J.2
Maine, N.3
Mendy, M.4
Whittle, H.C.5
-
108
-
-
84977067684
-
Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose
-
Bruce MG, Bruden D, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis 2016;214:16-22. https://doi. org/10.1093/infdis/jiv748
-
(2016)
J Infect Dis
, vol.214
, pp. 16-22
-
-
Bruce, M.G.1
Bruden, D.2
Hurlburt, D.3
-
109
-
-
79958775476
-
Hepatitis B and the need for a booster dose
-
Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011;53:68-75 https://doi.org/10.1093/cid/cir270
-
(2011)
Clin Infect Dis
, vol.53
, pp. 68-75
-
-
Leuridan, E.1
Van Damme, P.2
-
110
-
-
84977178314
-
A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen
-
Simons BC, Spradling PR, Bruden DJ, et al. A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen. J Infect Dis 2016;214:273-80. https://doi.org/10.1093/infdis/jiw142
-
(2016)
J Infect Dis
, vol.214
, pp. 273-280
-
-
Simons, B.C.1
Spradling, P.R.2
Bruden, D.J.3
-
111
-
-
0024961221
-
Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine
-
André FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med 1989;87(3a):S14-20. https://doi. org/10.1016/0002-9343(89)90525-1
-
(1989)
Am J Med
, vol.87
, Issue.3
, pp. S14-S20
-
-
André, F.E.1
-
112
-
-
84869786901
-
Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature
-
Schillie SF, Spradling PR, Murphy TV. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature. Diabetes Care 2012;35:2690-7. https://doi.org/10.2337/dc12-0312
-
(2012)
Diabetes Care
, vol.35
, pp. 2690-2697
-
-
Schillie, S.F.1
Spradling, P.R.2
Murphy, T.V.3
-
113
-
-
0032126559
-
Immunogenicity of hepatitis B Vaccines Implications for persons at occupational risk of hepatitis B virus infection
-
Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998;15:1-8. https://doi.org/10.1016/S0749-3797(98)00003-8
-
(1998)
Am J Prev Med
, vol.15
, pp. 1-8
-
-
Averhoff, F.1
Mahoney, F.2
Coleman, P.3
Schatz, G.4
Hurwitz, E.5
Margolis, H.6
-
114
-
-
0024465239
-
Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination
-
Shaw FE Jr, Guess HA, Roets JM, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989;7:425-30. https://doi. org/10.1016/0264-410X(89)90157-6
-
(1989)
Vaccine
, vol.7
, pp. 425-430
-
-
Shaw, F.E.1
Guess, H.A.2
Roets, J.M.3
-
115
-
-
84908278410
-
Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities
-
Bowman S, Grau LE, Singer M, Scott G, Heimer R. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities. BMC Public Health 2014;14:820. https://doi. org/10.1186/1471-2458-14-820
-
(2014)
BMC Public Health
, vol.14
, pp. 820
-
-
Bowman, S.1
Grau, L.E.2
Singer, M.3
Scott, G.4
Heimer, R.5
-
116
-
-
0024348726
-
Vaccination against hepatitis B in children and adolescent patients on dialysis
-
Drachman R, Isacsohn M, Rudensky B, Drukker A. Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol Dial Transplant 1989;4:372-4. https://doi.org/10.1093/ oxfordjournals.ndt.a091892
-
(1989)
Nephrol Dial Transplant
, vol.4
, pp. 372-374
-
-
Drachman, R.1
Isacsohn, M.2
Rudensky, B.3
Drukker, A.4
-
117
-
-
32844458617
-
Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis
-
Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006;332:328-36. https://doi.org/10.1136/bmj.38719.435833.7C
-
(2006)
BMJ
, vol.332
, pp. 328-336
-
-
Lee, C.1
Gong, Y.2
Brok, J.3
Boxall, E.H.4
Gluud, C.5
-
118
-
-
0031442363
-
Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants
-
Patel DM, Butler J, Feldman S, Graves GR, Rhodes PG. Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants. J Pediatr 1997;131:641-3. https://doi.org/10.1016/S0022-3476(97)70078-7
-
(1997)
J Pediatr
, vol.131
, pp. 641-643
-
-
Patel, D.M.1
Butler, J.2
Feldman, S.3
Graves, G.R.4
Rhodes, P.G.5
-
119
-
-
0032053422
-
A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults
-
Marsano LS, West DJ, Chan I, et al. A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults. Vaccine 1998;16:624-9. https://doi.org/10.1016/ S0264-410X(97)00233-8
-
(1998)
Vaccine
, vol.16
, pp. 624-629
-
-
Marsano, L.S.1
West, D.J.2
Chan, I.3
-
120
-
-
0035073194
-
A randomized trial of alternative two-and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory
-
Cassidy WM, Watson B, Ioli VA, Williams K, Bird S, West DJ. A randomized trial of alternative two-and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics 2001;107:626-31. https://doi. org/10.1542/peds.107.4.626
-
(2001)
Pediatrics
, vol.107
, pp. 626-631
-
-
Cassidy, W.M.1
Watson, B.2
Ioli, V.A.3
Williams, K.4
Bird, S.5
West, D.J.6
-
121
-
-
84863397336
-
Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials
-
Fabrizi F, Dixit V, Messa P, Martin P. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials. Vaccine 2012;30:2295-300. https:// doi.org/10.1016/j.vaccine.2012.01.064
-
(2012)
Vaccine
, vol.30
, pp. 2295-2300
-
-
Fabrizi, F.1
Dixit, V.2
Messa, P.3
Martin, P.4
-
122
-
-
0028864170
-
Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy
-
Hovi L, Valle M, Siimes MA, Jalanko H, Saarinen UM. Impaired response to hepatitis B vaccine in children receiving anticancer chemotherapy. Pediatr Infect Dis J 1995;14:931-4. https://doi. org/10.1097/00006454-199511000-00002
-
(1995)
Pediatr Infect Dis J
, vol.14
, pp. 931-934
-
-
Hovi, L.1
Valle, M.2
Siimes, M.A.3
Jalanko, H.4
Saarinen, U.M.5
-
123
-
-
0026661516
-
Impaired response to hepatitis B vaccine in HIV infected children
-
Zuin G, Principi N, Tornaghi R, et al. Impaired response to hepatitis B vaccine in HIV infected children. Vaccine 1992;10:857-60. https://doi.org/10.1016/0264-410X(92)90050-T
-
(1992)
Vaccine
, vol.10
, pp. 857-860
-
-
Zuin, G.1
Principi, N.2
Tornaghi, R.3
-
124
-
-
84904559120
-
-
Geneva, Switzerland: World Health Organization
-
World Health Organization. Information sheet observed rate of vaccine reactions: hepatitis B vaccine. Geneva, Switzerland: World Health Organization; 2012. http://www.who.int/vaccine_safety/initiative/ tools/Hep_B_Vaccine_rates_information_sheet.pdf
-
(2012)
Information sheet observed rate of vaccine reactions: hepatitis B vaccine
-
-
-
125
-
-
0141890074
-
Risk of anaphylaxis after vaccination of children and adolescents
-
Bohlke K, Davis RL, Marcy SM, et al.; Vaccine Safety Datalink Team. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003;112:815-20. https://doi.org/10.1542/peds.112.4.815
-
(2003)
Pediatrics
, vol.112
, pp. 815-820
-
-
Bohlke, K.1
Davis, R.L.2
Marcy, S.M.3
-
126
-
-
85018049937
-
-
Washington, DC: National Academy Press
-
Stratton K, Ford A, Rusch E, Clayton EW, eds. Adverse effects of vaccines: evidence and causality. Washington, DC: National Academy Press; 2012
-
(2012)
Adverse effects of vaccines: evidence and causality
-
-
Stratton, K.1
Ford, A.2
Rusch, E.3
Clayton, E.W.4
-
128
-
-
0032956631
-
Hepatitis B vaccine and central nervous system demyelinating diseases
-
Halsey NA, Duclos P, Van Damme P, Margolis H; Viral Hepatitis Prevention Board. Hepatitis B vaccine and central nervous system demyelinating diseases. Pediatr Infect Dis J 1999;18:23-4. https:// doi.org/10.1097/00006454-199901000-00007
-
(1999)
Pediatr Infect Dis J
, vol.18
, pp. 23-24
-
-
Halsey, N.A.1
Duclos, P.2
Van Damme, P.3
Margolis, H.4
-
129
-
-
34447275983
-
Hepatitis B vaccine and risk of multiple sclerosis
-
author reply 707-8
-
DeStefano F, Weintraub ES, Chen RT. Hepatitis B vaccine and risk of multiple sclerosis. Pharmacoepidemiol Drug Saf 2007;16:705-7, author reply 707-8. https://doi.org/10.1002/pds.1408
-
(2007)
Pharmacoepidemiol Drug Saf
, vol.16
, pp. 705-707
-
-
DeStefano, F.1
Weintraub, E.S.2
Chen, R.T.3
-
130
-
-
80051668808
-
Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age
-
Ray P, Black S, Shinefield H, et al.; Vaccine Safety Datalink Team. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age. Vaccine 2011;29:6592-7. https://doi.org/10.1016/j.vaccine.2011.06.112
-
(2011)
Vaccine
, vol.29
, pp. 6592-6597
-
-
Ray, P.1
Black, S.2
Shinefield, H.3
-
131
-
-
84860647162
-
Immunization and Bell's palsy in children: a case-centered analysis
-
Rowhani-Rahbar A, Klein NP, Lewis N, et al. Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol 2012;175:878-85. https://doi.org/10.1093/aje/kws011
-
(2012)
Am J Epidemiol
, vol.175
, pp. 878-885
-
-
Rowhani-Rahbar, A.1
Klein, N.P.2
Lewis, N.3
-
132
-
-
34547534648
-
Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study
-
Yu O, Bohlke K, Hanson CA, et al. Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf 2007;16:736-45. https://doi. org/10.1002/pds.1354
-
(2007)
Pharmacoepidemiol Drug Saf
, vol.16
, pp. 736-745
-
-
Yu, O.1
Bohlke, K.2
Hanson, C.A.3
-
133
-
-
70849100236
-
Risk of immune hemolytic anemia in children following immunization
-
Naleway AL, Belongia EA, Donahue JG, Kieke BA, Glanz JM; Vaccine Safety Datalink. Risk of immune hemolytic anemia in children following immunization. Vaccine 2009;27:7394-7. https://doi. org/10.1016/j.vaccine.2009.09.023
-
(2009)
Vaccine
, vol.27
, pp. 7394-7397
-
-
Naleway, A.L.1
Belongia, E.A.2
Donahue, J.G.3
Kieke, B.A.4
Glanz, J.M.5
-
134
-
-
84964888967
-
Risk of anaphylaxis after vaccination in children and adults
-
McNeil MM, Weintraub ES, Duffy J, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol 2016;137:868-78. https://doi.org/10.1016/j.jaci.2015.07.048
-
(2016)
J Allergy Clin Immunol
, vol.137
, pp. 868-878
-
-
McNeil, M.M.1
Weintraub, E.S.2
Duffy, J.3
-
135
-
-
84981263380
-
Casecentered analysis of optic neuritis after vaccines
-
Baxter R, Lewis E, Fireman B, DeStefano F, Gee J, Klein NP. Casecentered analysis of optic neuritis after vaccines. Clin Infect Dis 2016;63:79-81. https://doi.org/10.1093/cid/ciw224
-
(2016)
Clin Infect Dis
, vol.63
, pp. 79-81
-
-
Baxter, R.1
Lewis, E.2
Fireman, B.3
DeStefano, F.4
Gee, J.5
Klein, N.P.6
-
136
-
-
84879625683
-
Lack of association of Guillain-Barré syndrome with vaccinations
-
Baxter R, Bakshi N, Fireman B, et al. Lack of association of Guillain-Barré syndrome with vaccinations. Clin Infect Dis 2013;57:197-204. https://doi.org/10.1093/cid/cit222
-
(2013)
Clin Infect Dis
, vol.57
, pp. 197-204
-
-
Baxter, R.1
Bakshi, N.2
Fireman, B.3
-
137
-
-
84976872283
-
Suddenonset sensorineural hearing loss after immunization: a case-centered analysis
-
Baxter R, Lewis N, Bohrer P, Harrington T, Aukes L, Klein NP. Suddenonset sensorineural hearing loss after immunization: a case-centered analysis. Otolaryngol Head Neck Surg 2016;155:81-6. https://doi. org/10.1177/0194599816639043
-
(2016)
Otolaryngol Head Neck Surg
, vol.155
, pp. 81-86
-
-
Baxter, R.1
Lewis, N.2
Bohrer, P.3
Harrington, T.4
Aukes, L.5
Klein, N.P.6
-
139
-
-
0024515732
-
Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians
-
Hadler SC, de Monzon MA, Lugo DR, Perez M. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 1989;7:106-10. https://doi.org/10.1016/0264-410X(89)90046-7
-
(1989)
Vaccine
, vol.7
, pp. 106-110
-
-
Hadler, S.C.1
de Monzon, M.A.2
Lugo, D.R.3
Perez, M.4
-
140
-
-
0033038666
-
Hepatitis B vaccine administered to children and adolescents at yearly intervals
-
Halsey NA, Moulton LH, O'Donovan JC, et al. Hepatitis B vaccine administered to children and adolescents at yearly intervals. Pediatrics 1999;103:1243-7. https://doi.org/10.1542/peds.103.6.1243
-
(1999)
Pediatrics
, vol.103
, pp. 1243-1247
-
-
Halsey, N.A.1
Moulton, L.H.2
O'Donovan, J.C.3
-
141
-
-
0033597204
-
Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose
-
Wiström J, Ahlm C, Lundberg S, Settergren B, Tärnvik A. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine 1999;17:2162-5. https://doi. org/10.1016/S0264-410X(99)00012-2
-
(1999)
Vaccine
, vol.17
, pp. 2162-2165
-
-
Wiström, J.1
Ahlm, C.2
Lundberg, S.3
Settergren, B.4
Tärnvik, A.5
-
142
-
-
0024435696
-
Vaccination against hepatitis B: comparison of three different vaccination schedules
-
Jilg W, Schmidt M, Deinhardt F. Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis 1989;160:766-9. https://doi.org/10.1093/infdis/160.5.766
-
(1989)
J Infect Dis
, vol.160
, pp. 766-769
-
-
Jilg, W.1
Schmidt, M.2
Deinhardt, F.3
-
143
-
-
84942481625
-
Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization
-
Tan KL, Goh KT, Oon CJ, Chan SH. Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization. JAMA 1994;271:859-61. https://doi.org/10.1001/ jama.1994.03510350069039
-
(1994)
JAMA
, vol.271
, pp. 859-861
-
-
Tan, K.L.1
Goh, K.T.2
Oon, C.J.3
Chan, S.H.4
-
144
-
-
84951761513
-
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and metaanalysis
-
Brown RS Jr, McMahon BJ, Lok AS, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and metaanalysis. Hepatology 2016;63:319-33. https://doi.org/10.1002/hep.28302
-
(2016)
Hepatology
, vol.63
, pp. 319-333
-
-
Brown, R.S.1
McMahon, B.J.2
Lok, A.S.3
-
145
-
-
84981186408
-
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebocontrolled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
-
Jourdain G, Ngo-Giang-Huong N, Cressey TR, et al. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebocontrolled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. BMC Infect Dis 2016;16:393. https:// doi.org/10.1186/s12879-016-1734-5
-
(2016)
BMC Infect Dis
, vol.16
, pp. 393
-
-
Jourdain, G.1
Ngo-Giang-Huong, N.2
Cressey, T.R.3
-
146
-
-
84936845819
-
Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection
-
Han GR, Jiang HX, Yue X, et al. Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection. J Viral Hepat 2015;22:754-62. https://doi.org/10.1111/jvh.12379
-
(2015)
J Viral Hepat
, vol.22
, pp. 754-762
-
-
Han, G.R.1
Jiang, H.X.2
Yue, X.3
-
147
-
-
84963815216
-
Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection
-
Fan L, Owusu-Edusei K Jr, Schillie SF, Murphy TV. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection. Hepatology 2016;63:1471-80. https://doi.org/10.1002/hep.28310
-
(2016)
Hepatology
, vol.63
, pp. 1471-1480
-
-
Fan, L.1
Owusu-Edusei, K.2
Schillie, S.F.3
Murphy, T.V.4
-
148
-
-
84893312958
-
Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program
-
Barbosa C, Smith EA, Hoerger TJ, et al. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program. Pediatrics 2014;133:243-53. https://doi.org/10.1542/peds.2013-0718
-
(2014)
Pediatrics
, vol.133
, pp. 243-253
-
-
Barbosa, C.1
Smith, E.A.2
Hoerger, T.J.3
-
149
-
-
84872025206
-
Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes
-
Hoerger TJ, Schillie S, Wittenborn JS, et al. Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetes. Diabetes Care 2013;36:63-9 10.2337/dc12-0759. https://doi.org/10.2337/dc12-0759
-
(2013)
Diabetes Care
, vol.36
, pp. 63-69
-
-
Hoerger, T.J.1
Schillie, S.2
Wittenborn, J.S.3
-
150
-
-
84902975012
-
Costeffectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel
-
Hoerger TJ, Bradley C, Schillie SF, Reilly M, Murphy TV. Costeffectiveness of ensuring hepatitis B protection for previously vaccinated healthcare personnel. Infect Control Hosp Epidemiol 2014;35:845-54. https://doi.org/10.1086/676865
-
(2014)
Infect Control Hosp Epidemiol
, vol.35
, pp. 845-854
-
-
Hoerger, T.J.1
Bradley, C.2
Schillie, S.F.3
Reilly, M.4
Murphy, T.V.5
-
151
-
-
79551646111
-
General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
CDC. General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(No. RR-2):1-64
-
(2011)
MMWR Recomm Rep
, vol.60
, Issue.RR-2
, pp. 1-64
-
-
|